Nao Kino

420 total citations
22 papers, 301 citations indexed

About

Nao Kino is a scholar working on Oncology, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Nao Kino has authored 22 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Obstetrics and Gynecology and 7 papers in Molecular Biology. Recurrent topics in Nao Kino's work include Endometrial and Cervical Cancer Treatments (9 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Nao Kino is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Nao Kino collaborates with scholars based in Japan, Australia and Georgia. Nao Kino's co-authors include Toshiharu Yasugi, Y. Nakajima, Tomoko Kashiyama, Ayumi Taguchi, Kei Kawana, Hiroyuki Yoshikawa, Tomoko Gotō, Michiko Takahashi, Masashi Takano and Katsuyuki Karasawa and has published in prestigious journals such as British Journal of Cancer, Vaccine and Gynecologic Oncology.

In The Last Decade

Nao Kino

20 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nao Kino Japan	11	104	97	96	76	61	22	301
Dae Hoon Jeong South Korea	13	128 1.2×	122 1.3×	184 1.9×	78 1.0×	55 0.9×	41	464
Theofano Orfanelli United States	9	100 1.0×	83 0.9×	103 1.1×	49 0.6×	49 0.8×	31	352
Gauri Gandhi India	12	78 0.8×	146 1.5×	134 1.4×	44 0.6×	50 0.8×	36	398
Franco Gorlero Italy	10	49 0.5×	50 0.5×	143 1.5×	85 1.1×	54 0.9×	24	383
Maria Grazia Centurioni Italy	10	70 0.7×	48 0.5×	73 0.8×	73 1.0×	86 1.4×	23	308
Diego D’Ávila Paskulin Brazil	12	107 1.0×	98 1.0×	105 1.1×	56 0.7×	12 0.2×	21	381
Kevin R. Brader United States	11	109 1.0×	86 0.9×	81 0.8×	157 2.1×	139 2.3×	14	370
Fang‐Yu Chao Taiwan	9	61 0.6×	212 2.2×	80 0.8×	53 0.7×	162 2.7×	11	353
Zi Liu China	12	99 1.0×	86 0.9×	87 0.9×	90 1.2×	81 1.3×	24	310
Ömer Topalak Türkiye	10	60 0.6×	90 0.9×	55 0.6×	13 0.2×	125 2.0×	24	303

Countries citing papers authored by Nao Kino

Since Specialization

Citations

This map shows the geographic impact of Nao Kino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nao Kino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nao Kino more than expected).

Fields of papers citing papers by Nao Kino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nao Kino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nao Kino. The network helps show where Nao Kino may publish in the future.

Co-authorship network of co-authors of Nao Kino

This figure shows the co-authorship network connecting the top 25 collaborators of Nao Kino. A scholar is included among the top collaborators of Nao Kino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nao Kino. Nao Kino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurokawa, Mariko, Wataru Gonoi, Shouhei Hanaoka, et al.. (2025). High visceral-to-subcutaneous fat area ratio is an unfavorable prognostic indicator in patients with uterine sarcoma. Japanese Journal of Radiology. 43(10). 1670–1677.

Pitsillou, Eleni, Julia Liang, Nao Kino, et al.. (2024). An In Silico Investigation of the Pathogenic G151R G Protein-Gated Inwardly Rectifying K+ Channel 4 Variant to Identify Small Molecule Modulators. Biology. 13(12). 992–992. 1 indexed citations

Yomota, Makiko, Toru Motoi, Tatsuya Sato, et al.. (2024). Case Report: Structurally Rare EML4-ALK Identified by Next Generation Sequencing in a Patient with NSCLC with Bilateral Ovarian Metastases. OncoTargets and Therapy. Volume 17. 777–783.

Ito, Kei, Y. Nakajima, Keiko Nemoto Murofushi, et al.. (2024). Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy. Japanese Journal of Radiology. 42(8). 909–917. 3 indexed citations

Ebata, Takahiro, Satoshi Yamashita, Hideyuki Takeshima, et al.. (2022). DNA methylation marker to estimate ovarian cancer cell fraction. Medical Oncology. 39(5). 78–78. 5 indexed citations

Ebata, Takahiro, Satoshi Yamashita, Hideyuki Takeshima, et al.. (2022). DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer. Gynecologic Oncology. 167(3). 513–518. 4 indexed citations

Taguchi, Ayumi, et al.. (2021). High neutrophil‐to‐lymphocyte ratio is a predictor of short‐term survival for patients with recurrent cervical cancer after radiation‐based therapy. Journal of obstetrics and gynaecology research. 47(5). 1862–1870. 6 indexed citations

Taguchi, Ayumi, Kei Ito, Y. Nakajima, et al.. (2020). Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study. International Journal of Clinical Oncology. 25(5). 955–962. 21 indexed citations

Ito, Kei, Y. Nakajima, Hiroaki Ogawa, et al.. (2019). Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study. Japanese Journal of Clinical Oncology. 49(9). 856–861. 21 indexed citations

10.

Taguchi, Ayumi, et al.. (2019). A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy. International Journal of Gynecological Cancer. 29(1). 17–22. 32 indexed citations

11.

Taguchi, Ayumi, Masaya Uno, Satoshi Okada, et al.. (2018). A case of mature cystic teratoma with intestinal structures harboring intestinal-type low-grade mucinous neoplasm. International Cancer Conference Journal. 7(2). 59–64. 2 indexed citations

12.

Taguchi, Ayumi, Tomoko Kashiyama, Masaya Uno, et al.. (2018). Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer. International Journal of Clinical Oncology. 24(4). 428–436. 6 indexed citations

13.

Mori, Mayuyo, et al.. (2014). Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis. Journal of obstetrics and gynaecology research. 41(2). 324–328. 16 indexed citations

14.

Takano, Masashi, J Hirata, Mamoru Takahashi, et al.. (2013). UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study.. PubMed. 34(2). 120–3. 5 indexed citations

15.

Kazumoto, Tomoko, Shingo Kato, Harushige Yokota, et al.. (2011). Is a Low Dose of Concomitant Chemotherapy With Extended-Field Radiotherapy Acceptable as an Efficient Treatment for Cervical Cancer Patients With Metastases to the Para-Aortic Lymph Nodes?. International Journal of Gynecological Cancer. 21(8). 1465–1471. 7 indexed citations

16.

Takano, Masashi, Masafumi Kato, Tomoyuki Yoshikawa, et al.. (2009). Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers. Oncology. 76(5). 315–321. 46 indexed citations

17.

Gotō, Tomoko, et al.. (2005). Late recurrence of invasive cervical cancer: Twenty years’ experience in a single cancer institute. Journal of obstetrics and gynaecology research. 31(6). 514–519. 14 indexed citations

18.

Kawana, Kei, Toshiharu Yasugi, Tadahito Kanda, et al.. (2003). Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers. Vaccine. 21(27-30). 4256–4260. 52 indexed citations

19.

Nakagawa, Shunsuke, Hiroyuki Yoshikawa, Haruko Jimbo, et al.. (1999). Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations. British Journal of Cancer. 79(7-8). 1139–1144. 10 indexed citations

20.

Nakagawa, Shunsuke, Hiroyuki Yoshikawa, Kei Kawana, et al.. (1999). A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. British Journal of Cancer. 79(3-4). 589–594. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact